Top news

View all

7 February 2023

Gavi welcomes appointment of global health leader and malaria expert Dr Rose Leke as Chair of Independent Review Committee

The Gavi Independent Review Committee (IRC) is responsible for reviewing all applications for new funding support submitted by Gavi-eligible countries.

3 February 2023

Gavi and Government of India establish new partnership to protect millions of children by 2026

Gavi will provide US$ 250 million in funding to reach zero-dose children – those who have not received a single routine vaccine shot – through a renewed strategic partnership with the Government of India

25 January 2023

COVID-19 Vaccine Delivery Partnership boosts Sierra Leone COVID-19 Vaccination with US$ 2.8 million worth donation

COVID-19 Vaccine Delivery Partnership, (CoVDP) has handed over vehicles, motorbikes and computers worth of US$ 2.8M to support Sierra Leone Vaccination efforts.

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published every two weeks.

View all

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

 

 

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

8 February 2023

Burundi’s COVID-19 vaccination campaign accelerates

With just 0.25% of the country immunised, Burundi is dangerously behind the rest of the world when it comes to protection from the pandemic virus. But, a revamped strategy is pushing the pace of vaccination. 

8 February 2023

United in crisis: Nigeria battles diphtheria

Kano state sits at the epicentre of an outbreak of the vaccine-preventable disease, which has so far killed 38 and hospitalised many more. Though the region has a reputation for vaccine hesitancy, families are stepping up to help the health…

8 February 2023

Saving babies with a US$1 smart glove

A US$1 surgical glove fitted with nanocomposite sensors helps detect fetal position in labour.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Syringe >981 million children immunised
First aid locator >16.2 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >185.3 US$ billion in economic benefits for countries (2000–2021)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter